nsv917777
- Organism: Homo sapiens
- Study:nstd75 (ClinGen Prenatal)
- Variant Type:copy number variation
- Method Type:Oligo aCGH
- Submitted on:NCBI36 (hg18)
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:54,995
- Publication(s):Wapner et al. 2012
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 421 SVs from 64 studies. See in: genome view
Overlapping variant regions from other studies: 214 SVs from 46 studies. See in: genome view
Overlapping variant regions from other studies: 228 SVs from 35 studies. See in: genome view
Overlapping variant regions from other studies: 185 SVs from 21 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nsv917777 | Remapped | Good | GRCh38.p12 | Primary Assembly | First Pass | NC_000012.12 | Chr12 | 43,334 | 94,474 |
nsv917777 | Remapped | Good | GRCh38.p12 | ALT_REF_LOCI_1 | Second Pass | NW_003571049.1 | Chr12|NW_0 03571049.1 | 33,495 | 88,489 |
nsv917777 | Remapped | Pass | GRCh37.p13 | PATCHES | First Pass | NW_003571048.1 | Chr12|NW_0 03571048.1 | 35,740 | 84,474 |
nsv917777 | Submitted genomic | NCBI36 (hg18) | Primary Assembly | NC_000012.10 | Chr12 | 20,690 | 73,901 |
Variant Call Information
Variant Call ID | Type | Sample ID | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Copy number |
---|---|---|---|---|---|---|---|---|
nssv1605802 | copy number loss | ISCA_ID_pn_1506 | Oligo aCGH | Probe signal intensity | Developmental delay AND/OR other significant developmental or morphological phenotypes | Benign | Submitter | 1 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nssv1605802 | Remapped | Good | NW_003571049.1:g.( ?_33495)_(88489_?) del | GRCh38.p12 | Second Pass | NW_003571049.1 | Chr12|NW_0 03571049.1 | 33,495 | 88,489 |
nssv1605802 | Remapped | Good | NC_000012.12:g.(?_ 43334)_(94474_?)de l | GRCh38.p12 | First Pass | NC_000012.12 | Chr12 | 43,334 | 94,474 |
nssv1605802 | Remapped | Pass | NW_003571048.1:g.( ?_35740)_(84474_?) del | GRCh37.p13 | First Pass | NW_003571048.1 | Chr12|NW_0 03571048.1 | 35,740 | 84,474 |
nssv1605802 | Submitted genomic | NC_000012.10:g.(?_ 20690)_(73901_?)de l | NCBI36 (hg18) | NC_000012.10 | Chr12 | 20,690 | 73,901 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | Sample ID | HGVS | Type | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Gender | Age | Copy number |
---|---|---|---|---|---|---|---|---|---|
nssv1605802 | ISCA_ID_pn_1506 | NCBI36: NC_000012.10:g.(?_20690)_(73901_?)del | copy number loss | Developmental delay AND/OR other significant developmental or morphological phenotypes | Benign | Submitter | Female | 11 weeks gestation | 1 |